Carcinoma in situ, other/unspecified

PheWeb

CD2_INSITU_NOS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D09.7&, D09.9&

Hospital discharge: ICD-9 234[8-9]

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 D09.7&, D09.9&

Cause of death: ICD-9 234[8-9]

Cause of death: ICD-8 $!$

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

CD2_INSITU_NOS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ, other/unspecified based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	9	5	-
Unadjusted prevalence (%)	0.00	0.00	-
Mean age at first event (years)	68.21	66.83	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_INSITU_NOS – Carcinoma in situ, other/unspecified
GWS hits:

Survival analyses between endpoints

↥

Plot

before Carcinoma in situ, other/unspecified
after Carcinoma in situ, other/unspecified

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Carcinoma in situ, other/unspecified

↥